Duodenal atresia
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
For patient information, click here
Synonyms and keywords: Atresia of duodenum, atresia duodenum, duodenal stenosis.
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
Duodenal atresia is the congenital absence or complete closure of a portion of the lumen of the duodenum. Intestinal atresia, including duodenal atresia, may be classified into four subtypes: Type I, Type II, Type III, and Type IV. Type I is the most common subtype which involves the complete mucosal membrane, with muscularis and serosa remaining intact. The prevalance of duodenal atresia is 0.1 to 0.4 per 100000. It commonly affects neonates and has a male to female ratio of 2 to 1. The symptoms of duodenal atresia usually develop in the first 48 hours of life, and start with symptoms such as bilious vomiting in 80% of the cases. Prognosis is generally very good, and the survival rate of patients with duodenal atresia is approximately 90%.
Historical Perspective
In 1900, J. Tandler reported duodenal stenosis due to failure of recanalization of duodenum during fetal development in pregnancy. In 1961, Thomas Santulli and William Blanc described the figure 8 formation of small bowel, which is described as apple-peel intestinal atresia. In 1936, William Ladd developed a surgical procedure to correct the duodenal malrotation.
Classification
Intestinal atresia, including duodenal atresia, may be classified into four subtypes: Type I, Type II, Type III, and Type IV. Type I is the most common subtype which involves the complete mucosal membrane, with muscularis and serosa remaining intact.
Pathophysiology
It is thought that duodenal atresia is the result of failure of neural cell migration during the 8th to 10th week of duodenal re-canalization. It is associated with down syndrome, vertebral defects, anal anomalies, esophageal atresia, annular pancreas, malrotation, renal abnormalities, cardiac causes, and mandibulofacial anomalies.
Causes
The cause of duodenal atresia has not been identified.
Differentiating duodenal atresia from Other Diseases
Duodenal atresia must be differentiated from other diseases that cause persistent vomiting, and feeding difficulties, such as volvulus, jejuno-ileal atresia, malrotation, and meconium ileus. It is differentiated based on imaging.
Epidemiology and Demographics
The prevalance of duodenal atresia is 0.1 to 0.4 per 100000. It commonly affects neonates and has a male to female ratio of 2 to 1.
Risk Factors
The most potent risk factor in the development of duodenal atresia is down syndrome. Other risk factors include annular pancreas, and VACTERL syndrome.
Screening
There is insufficient evidence to recommend routine screening for duodenal atresia. However, screening for down syndrome may show duodenal atresia during pregnancy.
Natural History, Complications, and Prognosis
The symptoms of duodenal atresia usually develop in the first 48 hours of life, and start with symptoms such as bilious vomiting in 80% of the cases. Prognosis is generally very good, and the survival rate of patients with duodenal atresia is approximately 90%.
Diagnosis
Diagnostic Criteria
Duodenal atresia does not have a diagnostic study of choice. However, abdominal x-ray and ultrasound can confirm duodenal atresia.
History and Symptoms
The hallmark of duodenal atresia is bilious emesis with in the first 48 hours of life. A positive history of persistent emesis and feeding difficulties is suggestive of duodenal atresia. The most common symptoms of duodenal atresia include bilious emesis, persistent emesis, and feeding difficulties.
Physical Examination
Common physical examination findings of duodenal atresia include abdominal distension, dehydration, and restlessness.
Laboratory Findings
Laboratory findings consistent with the diagnosis of duodenal atresia include polyhydramnios on prenatal ultrasound, hypokalemia, and hyperchloremia.
Electrocardiogram
There are no ECG findings associated with duodenal atresia.
X-ray
An abdominal x-ray may be helpful in the diagnosis of duodenal atresia. Findings on the abdominal x-ray diagnostic of duodenal atresia include double bubble sign which is indicative of gas present in the stomach and absent in the distal small intestine.
Ultrasound
Ultrasound may be helpful in the diagnosis of duodenal atresia. Findings on ultrasound suggestive of duodenal atresia include polyhydramnios in pregnancy, and air fluid levels in the stomach with absent gas in the distal colon. Echocardiography can be performed to check for cardiac defect in infants with associated down syndrome.
CT scan
The CT scan findings associated with duodenal atresia are similar to the abdominal x-ray and ultrasound findings.
MRI
The MRI findings associated with duodenal atresia are similar to the abdominal x-ray and ultrasound findings.
Other Imaging Findings
Barium swallow study can be performed post operatively in duodenal atresia to make sure there is no leak in the anastomosis.
Other Diagnostic Studies
There are no other diagnostic studies associated with duodenal atresia.
Treatment
Medical Therapy
There is no medical treatment for duodenal atresia. Medical management to consider in duodenal atresia in preparation for surgery are orogastric decompression of the stomach, fluid resuscitation, broad-spectrum antibiotics, and vitamin K.
Surgery
Surgery is the mainstay of treatment for duodenal atresia. A nasogastric or orogastric tube should be inserted to decompress the abdomen. A laparotomy or laparoscopy can be performed to correct duodenal atresia. Surgical procedures include duodenoduodenostomy, and duodenojejunostomy.
Primary Prevention
There are no established measures for the primary prevention of duodenal atresia.
Secondary Prevention
Effective measures for the secondary prevention of duodenal atresia include prenatal ultrasound, postnatal abdominal x-ray and ultrasound, and surgical repair.
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
In 1900, J. Tandler reported duodenal stenosis due to failure of recanalization of duodenum during fetal development in pregnancy. In 1961, Thomas Santulli and William Blanc described the figure 8 formation of small bowel, which is described as apple-peel intestinal atresia. In 1936, William Ladd developed a surgical procedure to correct the duodenal malrotation.
Historical Perspective
Discovery
Duodenal atresia discovery is as follows:[1][2]
- In 1900, J. Tandler was the first to discover the association of duodenal stenosis due to failure of recanalization of the embryonic duodenum and the development of duodenal atresia.
- In 1961, Thomas V. Santulli and William A. Blanc described apple-peel intestinal atresia, which is the figure 8 formation of the small bowel.
Landmark Events in the Development of Treatment Strategies
- In 1936, a surgical procedure was developed by William Ladd to to correct the malrotation of duodenal atresia.[3]
References
- ↑ Tandler J. Zur entwicklungsdes chichte des menschlichen duodenum in fruhen embry-onalstedien. Morphol Jahrb 1900; 29: 187
- ↑ SANTULLI TV, BLANC WA (1961). “Congenital atresia of the intestine: pathogenesis and treatment”. Ann Surg. 154: 939–48. PMC 1465932. PMID 14497096.
- ↑ Morris, Grant; Kennedy, Alfred; Cochran, William (2016). “Small Bowel Congenital Anomalies: a Review and Update”. Current Gastroenterology Reports. 18 (4). doi:10.1007/s11894-016-0490-4. ISSN 1522-8037.
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
Intestinal atresia, including duodenal atresia, may be classified into four subtypes: Type I, Type II, Type III, and Type IV. Type I is the most common subtype which involves the complete mucosal membrane, with muscularis and serosa remaining intact.
Classification
- Intestinal atresia may be classified into several subtypes based on the location of the intestinal atresia:[1][2]
- Duodenum
- Type I
- Involves complete mucosal membrane or diaphragm
- Muscularis and serosa remaining intact
- No discontinuation of the bowel
- Type II
- Type III
- Type IV
- Several absent areas of bowel
- String of sausage appearance
- Type I
- Jejunum
- Ileum
- Duodenum
| Intestinal atresia according to the origin of the abnormality | |||||||||||||||||||||||||||||||||||||||
| Duodenum | Jejunum | Ileum | |||||||||||||||||||||||||||||||||||||
| •Type I •Type II •Type III •Type IV | |||||||||||||||||||||||||||||||||||||||
References
- ↑ Morris, Grant; Kennedy, Alfred; Cochran, William (2016). “Small Bowel Congenital Anomalies: a Review and Update”. Current Gastroenterology Reports. 18 (4). doi:10.1007/s11894-016-0490-4. ISSN 1522-8037.
- ↑ Kao KJ, Fleischer R, Bradford WD, Woodard BH (1983). “Multiple congenital septal atresias of the intestine: histomorphologic and pathogenetic implications”. Pediatr Pathol. 1 (4): 443–8. PMID 6687294.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
It is thought that duodenal atresia is the result of failure of neural cell migration during the 8th to 10th week of duodenal re-canalization. It is associated with down syndrome, vertebral defects, anal anomalies, esophageal atresia, annular pancreas, malrotation, renal abnormalities, cardiac causes, and mandibulofacial anomalies.
Pathophysiology
Pathogenesis
- Duodenum starts developing during the 6th and 7th week of gestation.[1][2]
- Re-canalization occurs during the 8th to 10th week of gestation.
- It is thought that duodenal atresia is the result of failure of re-canalization of the duodenum in 8 to 10 weeks of fetal development.
- This is due to failure of neural cell migration

Genetics
- Duodenal atresia is not transmitted genetically.
Associated Conditions
Duodenal atresia is commonly associated with the following:[3][4]
- Down syndrome in 25 %to 40% of cases
- VATER
- Vertebral defects
- Anal anomalies
- Esophageal atresia
- Renal abnormalities
- Malrotation
- Annular pancreas
- Biliary tract abnormalities
- Cardiac anomalies
- Mandibulofacial anomalies
References
- ↑ Ando H, Kaneko K, Ito F, Seo T, Harada T, Watanabe Y (1999). “Embryogenesis of pancreaticobiliary maljunction inferred from development of duodenal atresia”. J Hepatobiliary Pancreat Surg. 6 (1): 50–4. PMID 10436237.
- ↑ Boyden EA, Cope JG, Bill AH (1967). “Anatomy and embryology of congenital intrinsic obstruction of the duodenum”. Am J Surg. 114 (2): 190–202. PMID 6028984.
- ↑ Freeman, SB; Torfs, CP; Romitti, PA; Royle, MH; Druschel, C; Hobbs, CA; Sherman, SL (2009). “Congenital gastrointestinal defects in Down syndrome: a report from the Atlanta and National Down Syndrome Projects”. Clinical Genetics. 75 (2): 180–184. doi:10.1111/j.1399-0004.2008.01110.x. ISSN 0009-9163.
- ↑ Morris, Grant; Kennedy, Alfred; Cochran, William (2016). “Small Bowel Congenital Anomalies: a Review and Update”. Current Gastroenterology Reports. 18 (4). doi:10.1007/s11894-016-0490-4. ISSN 1522-8037.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
The cause of duodenal atresia has not been identified. To review risk factors for the development of duodenal atresia, click here.
Causes
Life-threatening Causes
- There are no life-threatening causes of duodenal atresia, however complications resulting from untreated duodenal atresia is common.
Genetic Causes
- There are no known genetic causes of duodenal atresia.
Causes by Organ System
| Cardiovascular | No underlying causes |
| Chemical/Poisoning | No underlying causes |
| Dental | No underlying causes |
| Dermatologic | No underlying causes |
| Drug Side Effect | No underlying causes |
| Ear Nose Throat | No underlying causes |
| Endocrine | No underlying causes |
| Environmental | No underlying causes |
| Gastroenterologic | No underlying causes |
| Genetic | No underlying causes |
| Hematologic | No underlying causes |
| Iatrogenic | No underlying causes |
| Infectious Disease | No underlying causes |
| Musculoskeletal/Orthopedic | No underlying causes |
| Neurologic | No underlying causes |
| Nutritional/Metabolic | No underlying causes |
| Obstetric/Gynecologic | No underlying causes |
| Oncologic | No underlying causes |
| Ophthalmologic | No underlying causes |
| Overdose/Toxicity | No underlying causes |
| Psychiatric | No underlying causes |
| Pulmonary | No underlying causes |
| Renal/Electrolyte | No underlying causes |
| Rheumatology/Immunology/Allergy | No underlying causes |
| Sexual | No underlying causes |
| Trauma | No underlying causes |
| Urologic | No underlying causes |
| Miscellaneous | No underlying causes |
References
Differentiating Duodenal atresia from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
Duodenal atresia must be differentiated from other diseases that cause persistent vomiting, and feeding difficulties, such as volvulus, jejuno-ileal atresia, malrotation, and meconium ileus. It is differentiated based on imaging.
Differentiating duodenal atresia from other Diseases
- Duodenal atresia must be differentiated from other diseases that cause persistent vomiting, and feeding difficulties, such as volvulus, jejuno-ileal atresia, and malrotation.[1][2][3]
| Diseases | History and Symptoms | Physical Examination | Laboratory Findings | Other Findings | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vomiting | Feeding difficulty | Stool present | Bilious vomitus | Abdominal distension | Abdominal tenderness | Dehydrated | Abdominal ultrasound | Abdominal x-ray | Electrolytes | ||
| Duodenal Atresia | + | + | +/- | + | +/- | + | + | Gas in stomach with absent gas in small intestine | Stomach distension and air fluid levels
Double bubble sign |
Hypokalemia | Down syndrome |
| Jejuno-ileal atresia | + | + | +/- | + | + | + | + | Gas in stomach with no gas in colon | Stomach and proximal small intestine distension | Hypokalemia | |
| Volvulus | + | + | +/- | + | + | + | + | Spiral sign | Malrotation of intestine with gas in stomach and air fluid levels | Hypokalemia | |
| Meconium ileus | + | + | +/- | + | + | + | + | Distension | Air fluid levels | Hypokalemia | Cystic fibrosis |
References
- ↑ Adams, Stephen D.; Stanton, Michael P. (2014). “Malrotation and intestinal atresias”. Early Human Development. 90 (12): 921–925. doi:10.1016/j.earlhumdev.2014.09.017. ISSN 0378-3782.
- ↑ Morris, Grant; Kennedy, Alfred; Cochran, William (2016). “Small Bowel Congenital Anomalies: a Review and Update”. Current Gastroenterology Reports. 18 (4). doi:10.1007/s11894-016-0490-4. ISSN 1522-8037.
- ↑ Kimura K, Loening-Baucke V (2000). “Bilious vomiting in the newborn: rapid diagnosis of intestinal obstruction”. Am Fam Physician. 61 (9): 2791–8. PMID 10821158.
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
The prevalance of duodenal atresia is 0.1 to 0.4 per 100000. It commonly affects neonates and has a male to female ratio of 2 to 1.
Epidemiology and Demographics
The epidemiology and demographics of duodenal atresia are as follows:[1][2]
Incidence
- The incidence of intestinal atresia is:
Prevalence
- The prevalence of duodenal atresia is estimated to be 0.1 to 0.4 per 100000 of cases annually.
- About 60% of intestinal atresias
- 30% associated with down syndrome
Age
- Duodenal atresia commonly affects individuals in infancy.
Race
- There is no racial predilection to duodenal atresia.
Gender
References
- ↑ Best, Kate E; Tennant, Peter W G; Addor, Marie-Claude; Bianchi, Fabrizio; Boyd, Patricia; Calzolari, Elisa; Dias, Carlos Matias; Doray, Berenice; Draper, Elizabeth; Garne, Ester; Gatt, Miriam; Greenlees, Ruth; Haeusler, Martin; Khoshnood, Babak; McDonnell, Bob; Mullaney, Carmel; Nelen, Vera; Randrianaivo, Hanitra; Rissmann, Anke; Salvador, Joaquin; Tucker, David; Wellesly, Diana; Rankin, Judith (2012). “Epidemiology of small intestinal atresia in Europe: a register-based study”. Archives of Disease in Childhood – Fetal and Neonatal Edition. 97 (5): F353–F358. doi:10.1136/fetalneonatal-2011-300631. ISSN 1359-2998.
- ↑ Morris, Grant; Kennedy, Alfred; Cochran, William (2016). “Small Bowel Congenital Anomalies: a Review and Update”. Current Gastroenterology Reports. 18 (4). doi:10.1007/s11894-016-0490-4. ISSN 1522-8037.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
The most potent risk factor in the development of duodenal atresia is down syndrome. Other risk factors include annular pancreas, and VACTERL syndrome.
Risk Factors
The risk factors are as follows:[1][2][3]
- The most potent risk factor in the development of duodenal atresia is down syndrome.
- Other risk factors include annular pancreas, and VACTERL anomalies.
- Malrotation
- Annular pancreas
- Biliary tract abnormalities
- Mandibulofacial anomalies
Common Risk Factors
- Common risk factors in the development of duodenal atresia include:
- Down syndrome in 30% of the cases.
Less Common Risk Factors
- Malrotation
- Biliary tract abnormalities
References
- ↑ Freeman, SB; Torfs, CP; Romitti, PA; Royle, MH; Druschel, C; Hobbs, CA; Sherman, SL (2009). “Congenital gastrointestinal defects in Down syndrome: a report from the Atlanta and National Down Syndrome Projects”. Clinical Genetics. 75 (2): 180–184. doi:10.1111/j.1399-0004.2008.01110.x. ISSN 0009-9163.
- ↑ Morris, Grant; Kennedy, Alfred; Cochran, William (2016). “Small Bowel Congenital Anomalies: a Review and Update”. Current Gastroenterology Reports. 18 (4). doi:10.1007/s11894-016-0490-4. ISSN 1522-8037.
- ↑ Adams, Stephen D.; Stanton, Michael P. (2014). “Malrotation and intestinal atresias”. Early Human Development. 90 (12): 921–925. doi:10.1016/j.earlhumdev.2014.09.017. ISSN 0378-3782.
Screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
There is insufficient evidence to recommend routine screening for duodenal atresia. However, screening for down syndrome may show duodenal atresia during pregnancy.
Screening
- There is insufficient evidence to recommend routine screening for duodenal atresia.
Down Syndrome Screening
Screening for down syndrome is as follows:[1][2][3][4][5][6]
- Genetic counseling is usually offered to families who may have an increased chance of having a child with Down syndrome along with:
- genetic testing
- amniocentesis
- Involves inserting instruments into the uterus which carry a small risk of causing fetal injury.
- chorionic villus sampling (CVS)
- Involves inserting instruments into the uterus which carry a small risk of causing fetal injury.
- Percutaneous umbilical blood sampling (PUBS) are usually offered
- Common screening procedures for Down syndrome are given in Table 1.
| Screen | When performed (weeks gestation) | Detection rate | False positive rate | Description |
|---|---|---|---|---|
| Triple screen | 15–20 | 75% | 8.5% | This test measures the maternal serum alpha feto protein (a fetal liver protein), estriol (a pregnancy hormone), and human chorionic gonadotropin (hCG, a pregnancy hormone).[7] |
| Quad screen | 15–20 | 79% | 7.5% | This test measures the maternal serum alpha feto protein (a fetal liver protein), estriol (a pregnancy hormone), human chorionic gonadotropin (hCG, a pregnancy hormone), and high inhibin-Alpha (INHA).[7] |
| AFP/free beta screen | 13–22 | 80% | 2.8% | This test measures the alpha feto protein, produced by the fetus, and free beta hCG, produced by the placenta. |
| Nuchal translucency/free beta/PAPPA screen | 10–13.5 | 91%[8] | 5%[8] | Uses ultrasound to measure Nuchal Translucency in addition to the freeBeta hCG and PAPPA (pregnancy-associated plasma protein A). NIH has confirmed that this first trimester test is more accurate than second trimester screening methods.[9] |
References
- ↑ Eddleman, Keith A.; et al. (2006). “Pregnancy loss rates after midtrimester amniocentesis”. Obstet Gynecol. 108 (5): 1067–1072. Retrieved 2006-12-09. PMID 17077226
- ↑ Caroline Mansfield, Suellen Hopfer, Theresa M. Marteau (1999). “Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndromes: a systematic literature review”. Prenatal Diagnosis. 19 (9): 808–812. PMID 10521836 This is similar to 90% results found by David W. Britt, Samantha T. Risinger, Virginia Miller, Mary K. Mans, Eric L. Krivchenia, Mark I. Evans (1999). “Determinants of parental decisions after the prenatal diagnosis of Down syndrome: Bringing in context”. American Journal of Medical Genetics. 93 (5): 410–416. PMID 10951466
- ↑ Fackler, A. “Down syndrome”. Retrieved 2006-09-07.
- ↑ Will, George (2005-04-14). “Eugenics By Abortion: Is perfection an entitlement?”. Washington Post: A37. Retrieved 2006-07-03.
- ↑ Erik Parens and Adrienne Asch (2003). “Disability rights critique of prenatal genetic testing: Reflections and recommendations”. Mental Retardation and Developmental Disabilities Research Reviews. 9 (1): 40–47. Retrieved 2006-07-03. PMID 12587137
- ↑ Glover, NM and Glover, SJ (1996). “Ethical and legal issues regarding selective abortion of fetuses with Down syndrome”. Ment. Retard. 34 (4): 207–214. PMID 8828339.
- ↑ 7.0 7.1 For a current estimate of rates, see Benn, PA, J Ying, T Beazoglou, JFX Egan. “Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustments for cross-identification and double-positive results”. Prenatal Diagnosis. 21 (1): 46–51. PMID 11180240
- ↑ 8.0 8.1 Some practices report adding Nasal Bone measurements and increasing the detection rate to 95% with a 2% False Positive Rate.
- ↑ NIH FASTER study (NEJM 2005 (353):2001). See also J.L. Simplson’s editorial (NEJM 2005 (353):19).
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
The symptoms of duodenal atresia usually develop in the first 48 hours of life, and start with symptoms such as bilious vomiting in 80% of the cases. Prognosis is generally very good, and the survival rate of patients with duodenal atresia is approximately 90%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of duodenal atresia usually develop in the first 48 hours of life, and start with symptoms such as vomiting.[1]
- Bilious vomiting in 80% of the cases.
- Non-bilious vomiting in 20% of the cases.
- Dehydration
- If duodenal atresia is left untreated it will result in death.
Complications
The complications of duodenal atresia are as follows:[2][3]
- There are no complications associated with duodenal atresia, however post surgical complications may occur.
- Post surgical complications include:
- Adhesions
- Duodenal dysmotility
- Megaduodenum with blind loop syndrome
- Duodenogastric reflux and gastritis
- Peptic ulcer disease
- Gastroesophageal reflux
- Cholelithiasis
- Cholecystitis
Prognosis
- Prognosis is generally good, and the survival rate of patients with duodenal atresia is approximately 90% after surgery.[4]
References
- ↑ Adams, Stephen D.; Stanton, Michael P. (2014). “Malrotation and intestinal atresias”. Early Human Development. 90 (12): 921–925. doi:10.1016/j.earlhumdev.2014.09.017. ISSN 0378-3782.
- ↑ Spigland N, Yazbeck S (1990). “Complications associated with surgical treatment of congenital intrinsic duodenal obstruction”. J Pediatr Surg. 25 (11): 1127–30. PMID 2273425.
- ↑ Kokkonen ML, Kalima T, Jääskeläinen J, Louhimo I (1988). “Duodenal atresia: late follow-up”. J Pediatr Surg. 23 (3): 216–20. PMID 3357136.
- ↑ Escobar MA, Ladd AP, Grosfeld JL, West KW, Rescorla FJ, Scherer LR; et al. (2004). “Duodenal atresia and stenosis: long-term follow-up over 30 years”. J Pediatr Surg. 39 (6): 867–71, discussion 867-71. PMID 15185215.
Diagnosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Electrocardiogram | Laboratory Findings | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Diagnostic Studies | Other Imaging Findings
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
